Transplant International · 2004 · 17 citations · 16 references
Life SciencesImmunologyPathologyClinical ImmunologyImmunopathologyTransplant ImmunologyAcute RejectionAllograft RejectionAntibody-mediated RejectionGraft RejectionImmunosuppressionTransplant RejectionAcute Renal Allograft RejectionAntibody-mediated Rejection TherapyBiopsy Diagnosis Of RejectionC4 Complement LevelsC4d ImmunostainingComplement In Transplant RejectionHumoral Rejection
Abstract Acute humoral rejection (AHR) is currently perceived as an immunological reaction against donor antigens mediated by complement-binding antibodies. C4d, a split product of complement activation and bound to endothelial cells of the peritubular capillaries, is used as a diagnostic marker for AHR. We report on three patients with biopsyproven acute humoral rejection who were treated initially with plasmapheresis (PS). As two of the patients did not recover renal function, and biopsy showed persistent C4d staining after PS, immunoadsorption (IAS) was additionally performed on them. In all patients, renal function recovered, and follow-up biopsies in two patients showed complete disappearance of C4d, 29 days and 58 days after transplantation and only minimal residual C4d deposits in one patient 48 days after transplantation. We conclude that successful treatment of AHR is followed by complete resolution of serological and histological markers of AHR, displayed by the disappearance of C4d.
16
The Banff 97 working classification of renal allograft pathology
Lorraine C. Racusen, Kim Solez, Robert B. Colvin et al. · Kidney International · 1999 · 3.1K citations
Medicine, Nephrology, Pathology +17
Robert A. Montgomery, Andrea A. Zachary, Lorraine C. Racusen et al. · Transplantation · 2000 · 592 citations
Acute Humoral Rejection in Kidney Transplantation
Shamila Mauiyyedi, Marta Crespo, A. Bernard Collins et al. · Journal of the American Society of Nephrology · 2002 · 491 citations
Life Sciences, Immunology, Pathology +17